Stay updated on Durvalumab Combo in Advanced Liver Cancer Clinical Trial
Sign up to get notified when there's something new on the Durvalumab Combo in Advanced Liver Cancer Clinical Trial page.

Latest updates to the Durvalumab Combo in Advanced Liver Cancer Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoNo Change Detected
- Check21 days agoChange DetectedThe Publications section now states that publications are automatically filled from PubMed. A new revision label, v3.3.2, appears.SummaryDifference0.0%

- Check28 days agoChange DetectedThe general government funding status notice at the top of the ClinicalTrials.gov page was removed. This change does not affect study details, eligibility criteria, locations, or outcomes; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check35 days agoChange DetectedTainan City, Taiwan was removed and Tainan, Taiwan added in the Locations section.SummaryDifference0.0%

- Check42 days agoChange DetectedThe new screenshot shows minor visual/layout adjustments with no changes to the main study details such as eligibility, interventions, or endpoints. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check56 days agoChange DetectedPage metadata updated: newer dates and larger size added; older update markers and smaller size removed. Overall, this indicates a refresh of timing/size metadata rather than core content additions.SummaryDifference0.7%

- Check71 days agoChange DetectedUpdated study citation details to a newer, more complete bibliographic entry and added a government-operating-status notice; removed the previous earlier citation form.SummaryDifference2%

Stay in the know with updates to Durvalumab Combo in Advanced Liver Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Durvalumab Combo in Advanced Liver Cancer Clinical Trial page.